Monday, October 17, 2011

Kidney International - Table of Contents alert Volume 80 Issue 9


TABLE OF CONTENTS

Volume 80, Issue 9 (November 2011)

In this issue
In this Issue
Editorial
Nephrologists Sans Frontières
Journal Club
Commentaries
Review
Original Articles
Corrigenda
Nephrology Image

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
The Renin-Angiotensin System: Today and Tomorrow in Research and Clinical Practice
December 11-13, 2011 - Miami, FL, USA

The conference will bring together leaders in the field to present a comprehensive, authoritative update on renin-angiotensin system (RAS) inhibition for improved clinical outcomes and to explore future options for targeting the RAS and its related pathways.
www.nature.com/natureconferences/ras11
 

In this Issue

Top

In this Issue

Kidney Int 2011 80: 897; 10.1038/ki.2011.334

Full Text

Editorial

Top

A new admiral for the flagship

David Harris

Kidney Int 2011 80: 899; advance online publication, September 14, 2011; 10.1038/ki.2011.333

Full Text

Nephrologists Sans Frontières

Top

Recent outbreak of hemolytic uremic syndrome in Germany

Ulrich Kunzendorf, Helge Karch, Dirk Werber and Hermann Haller

Kidney Int 2011 80: 900-902; 10.1038/ki.2011.323

Full Text

Journal Club

Top

Journal Club

Kidney Int 2011 80: 903-904; 10.1038/ki.2011.335

Full Text

Commentaries

Top

Cyclooxygenase-2 in the kidney: good, BAD, or both?

S Russ Price and Janet D Klein

Kidney Int 2011 80: 905-907; 10.1038/ki.2011.263

Abstract | Full Text

A new regulator of the vacuolar H+-ATPase in the kidney

Dominique Eladari and Jacques Teulon

Kidney Int 2011 80: 907-909; 10.1038/ki.2011.220

Abstract | Full Text

Choice of dialysis modality

Rajnish Mehrotra

Kidney Int 2011 80: 909-911; 10.1038/ki.2011.262

Abstract | Full Text

Detrimental effects of dual ACEI–ARB therapy: is the (pro)renin receptor the culprit?

Fernando Elijovich and Cheryl L Laffer

Kidney Int 2011 80: 911-914; 10.1038/ki.2011.264

Abstract | Full Text

Review

Top

Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis

Hans-Joachim Anders and Mi Ryu

Kidney Int 2011 80: 915-925; advance online publication, August 3, 2011; 10.1038/ki.2011.217

Abstract | Full Text

Original Articles

Top

Slc26a11, a chloride transporter, localizes with the vacuolar H+-ATPase of A-intercalated cells of the kidney

Jie Xu, Sharon Barone, Hong Li, Shannon Holiday, Kamyar Zahedi and Manoocher Soleimani

Kidney Int 2011 80: 926-937; advance online publication, June 29, 2011; 10.1038/ki.2011.196

Abstract | Full Text

Cyclooxygenase-2-dependent phosphorylation of the pro-apoptotic protein Bad inhibits tonicity-induced apoptosis in renal medullary cells

Christoph Küper, Helmut Bartels, Franz-X Beck and Wolfgang Neuhofer

Kidney Int 2011 80: 938-945; advance online publication, June 29, 2011; 10.1038/ki.2011.199

Abstract | Full Text

Macrophages are essential contributors to kidney injury in murine cryoglobulinemic membranoproliferative glomerulonephritis

Shunhua Guo, Tomasz A Wietecha, Kelly L Hudkins, Yujiro Kida, Min W Spencer, Warangkana Pichaiwong, Ichiro Kojima, Jeremy S Duffield and Charles E Alpers

Kidney Int 2011 80: 946-958; advance online publication, August 3, 2011; 10.1038/ki.2011.249

Abstract | Full Text

Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II–mediated podocyte apoptosis

Hsiang-Hao Hsu, Sigrid Hoffmann, Giovana S Di Marco, Nicole Endlich, Jasna Peter-Katalinić, Thomas Weide and Hermann Pavenstädt

Kidney Int 2011 80: 959-969; advance online publication, August 3, 2011; 10.1038/ki.2011.250

Abstract | Full Text

Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure

Florence Sens, Anne-Marie Schott-Pethelaz, Michel Labeeuw, Cyrille Colin and Emmanuel Villar on behalf of the REIN Registry

Kidney Int 2011 80: 970-977; advance online publication, July 20, 2011; 10.1038/ki.2011.233

Abstract | Full Text

Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients

Kevin E Chan, T Alp Ikizler, Jorge L Gamboa, Chang Yu, Raymond M Hakim and Nancy J Brown

Kidney Int 2011 80: 978-985; advance online publication, July 20, 2011; 10.1038/ki.2011.228

Abstract | Full Text

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival

Shalabh Srivastava, Sarah Hildebrand and Stanley L.-S. Fan

Kidney Int 2011 80: 986-991; advance online publication, August 3, 2011; 10.1038/ki.2011.244

Abstract | Full Text

Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients

Vimal K Derebail, Patrick H Nachman, Nigel S Key, Heather Ansede, Ronald J Falk, Wayne D Rosamond and Abhijit V Kshirsagar

Kidney Int 2011 80: 992-999; advance online publication, August 17, 2011; 10.1038/ki.2011.247

Abstract | Full Text

Corrigenda

Top

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

Kidney Int 2011 80: 1000; 10.1038/ki.2011.310

Full Text

Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells

Kidney Int 2011 80: 1000-1001; 10.1038/ki.2011.321

Full Text

Nephrology Image

Top

Vanishing renal artery disease: a segmental arterial mediolysis story

Gerald Gahide, Stephan Servant and Marie F Giroux

Kidney Int 2011 80: 1002; 10.1038/ki.2011.279

Full Text

Advertisement
Nature Publishing Group invites you to visit Stand 415 at the American Society of Nephrology/Renal Week from November 8-12, 2011 in Philadelphia, PA.

Please stop by Stand 415 between November 8th and November 12th for complimentary copies of Kidney International, Nature Reviews Nephrology and other Nature Publishing Group journals.

Visit www.nature.com/ki and www.nature.com/nrneph to read current content, sign up for FREE e-alerts or submit your paper.
 

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Kidney International. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: